Inside Track: Detecting Ovarian Cancer
In this month’s Inside Track, Nadia Altomare, CEO of Abcodia, discusses how her company’s test can lead to improved clinical outcomes.
Read MorePosted by Elaine Sanchez Wilson | Jan 19, 2016 | Cancer, Unknown Origin & Other Cancer Types |
In this month’s Inside Track, Nadia Altomare, CEO of Abcodia, discusses how her company’s test can lead to improved clinical outcomes.
Read MorePosted by Elaine Sanchez Wilson | Jan 18, 2016 | Molecular Diagnostics |
The Progensa prostate cancer antigen 3 assay can help improve prediction of repeat biopsy outcomes in men who have had one or more prior negative prostate biopsies.
Read MorePosted by Elaine Sanchez Wilson | Dec 21, 2015 | Molecular Diagnostics |
Molecular panel tests are making inroads against complex genetic diseases.
Read MorePosted by Elaine Sanchez Wilson | Dec 18, 2015 | Information Technology |
Capabilities of the QCI bioinformatics platform have been expanded to include leukemia and lymphoma testing, as well as testing for hereditary cancer indications.
Read MorePosted by Steve Halasey | Dec 8, 2015 | Research |
Study will test the effectiveness of a high-sensitivity ELISA test for screening and detecting recurrence of bladder cancer.
Read More